Cleveland Clinic

The biopharmaceutical industry has been through a tremendous period of company creation, and even with a drop in financings during 2022 and 2023 from record levels of funding in 2020 and 2021, the las

The Novo Nordisk Foundation and the Broad Institute introduced a new Center for Genomic Mechanisms of Disease research unit on 15 September, to be housed at the Harvard University / Massachusetts I

Tumor-infiltrating lymphocytes have long been regarded as a promising modality for treating solid tumor cancers with cell therapy, but an ongoing challenge in tapping that potential has been manufactu

U. Of Texas Research Branch Maintains Hectic Partnering Pace The increasingly busy University of Texas MD Anderson Cancer Center inked three new alliances with biopharmaceutical companies in the pas